Caravel Oculus
PIPELINE
CA202L for Glaucoma
Our patented preservative-free formula is gentle on the cornea and prevents damage. The enhanced excipient formulation improves comfort, allows for room temperature storage, and increases patient compliance. Additionally, the new formula has potential therapeutic applications for retinal diseases, such as retinal stroke, and has been patented in 12 countries. It also helps alleviate dry eye symptoms, offering a more comprehensive eye health solution for patients.
CA201A for Cataract
This innovative drug addresses an unmet medical need by protecting corneal endothelial cells and reducing the risk of complications requiring corneal transplantation. It can be used in combination with post-cataract surgery treatments, such as antibiotics and steroids, to enhance therapeutic outcomes.Utilizing a drug repurposing strategy, it offers high safety and introduces a new formulation, new route of administration, and new indication. Overcoming stability challenges, we are now preparing for a patent application to secure our technological advantage.
Unmet Medical Need
